Citation: Dm. Rosenberg et al., Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients, AIDS, 15(2), 2001, pp. 211-214
Authors:
Clumeck, N
Goebel, F
Rozenbaum, W
Gerstoft, J
Staszewski, S
Montaner, J
Johnson, M
Gazzard, B
Stone, C
Athisegaran, R
Moore, S
Citation: N. Clumeck et al., Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA, AIDS, 15(12), 2001, pp. 1517-1526
Citation: J. Montaner et al., Practical implications for the interpretation of minimum plasma concentration/inhibitory concentration ratios, LANCET, 357(9266), 2001, pp. 1438-1440
Authors:
Staszewski, S
Keiser, P
Montaner, J
Raffi, F
Gathe, J
Brotas, V
Hicks, C
Hammer, SM
Cooper, D
Johnson, M
Tortell, S
Cutrell, A
Thorborn, D
Isaacs, R
Hetherington, S
Steel, H
Spreen, W
Citation: S. Staszewski et al., Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial, J AM MED A, 285(9), 2001, pp. 1155-1163
Authors:
Montaner, J
Alvarez-Sabin, J
Molina, C
Angles, A
Abilleira, S
Arenillas, J
Gonzalez, MA
Monasterio, J
Citation: J. Montaner et al., Matrix metalloproteinase expression after human cardioembolic stroke - Temporal profile and relation to neurological impairment, STROKE, 32(8), 2001, pp. 1759-1766
Authors:
Molina, CA
Montaner, J
Abilleira, S
Ibarra, B
Romero, F
Arenillas, JF
Alvarez-Sabin, J
Citation: Ca. Molina et al., Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke, STROKE, 32(5), 2001, pp. 1079-1084
Authors:
Montaner, J
Alvarez-Sabin, J
Molina, CA
Angles, A
Abilleira, S
Arenillas, J
Monasterio, J
Citation: J. Montaner et al., Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke, STROKE, 32(12), 2001, pp. 2762-2767
Authors:
Molina, CA
Montaner, J
Abilleira, S
Arenillas, JF
Ribo, M
Huertas, R
Romero, F
Alvarez-Sabin, J
Citation: Ca. Molina et al., Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke - A case-control study, STROKE, 32(12), 2001, pp. 2821-2827
Authors:
Montaner, J
Alvarez-Sabin, J
Abilleira, S
Molina, C
Arenillas, J
Codina, A
Citation: J. Montaner et al., Acute phase response after stroke: differences between ischemic stroke andintracerebral hemorrhage, MED CLIN, 116(2), 2001, pp. 54-55
Authors:
Sastre-Garriga, J
Molina, C
Montaner, J
Mauleon, A
Pujadas, F
Codina, A
Alvarez-Sabin, J
Citation: J. Sastre-garriga et al., Mitral papillary fibroelastoma as a cause of cardiogenic embolic stroke: report of two cases and review of the literature, EUR J NEUR, 7(4), 2000, pp. 449-453
Authors:
Montaner, J
Molina, C
Alvarez-Sabin, J
Codina, A
Citation: J. Montaner et al., 'Herald hemiparesis' of basilar artery occlusion: early recognition by transcranial Doppler ultrasound, EUR J NEUR, 7(1), 2000, pp. 91-93
Authors:
Babiker, A
Bartlett, J
Breckenridge, A
Collins, G
Coombs, R
Cooper, D
Creagh, T
Cross, A
Daniels, M
Darbyshire, J
Dawson, D
DeGruttola, V
DeMasi, R
Dolin, R
Eron, J
Fischl, M
Grossberg, S
Hamilton, J
Hammer, S
Hartigan, P
Henry, K
Hill, A
Hughes, M
Kahn, J
Katlama, C
Katzenstein, D
Kim, S
Mildvan, D
Montaner, J
Moore, M
Neaton, J
O'Brien, W
Ribaudo, H
Richman, D
Saag, M
Salgo, M
Saravolatz, L
Schooley, R
Seligmann, M
Staszewski, S
Struthers, L
Tierney, C
Tsiatis, A
Welles, S
Citation: A. Babiker et al., Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis, AIDS RES H, 16(12), 2000, pp. 1123-1133
Authors:
Gartland, M
Gerstoft, J
Goebel, F
Clumeck, N
Cooper, DA
Gatell, J
Gazzard, B
Gerstoft, J
Goebel, F
Lange, J
Montaner, J
Reiss, P
Rozenbaum, W
Vella, S
Beveridge, A
Cooper, DA
Duncombe, C
Gold, J
Haberl, M
Clumeck, N
Luyts, D
Montaner, J
Rachlis, A
Marina, R
Gerstoft, J
Wandall, JH
Elbrond, B
Molina, JM
Pialloux, G
Rozenbaum, W
Beauvais, L
Goebel, FD
Staszewski, S
Bruns, I
Hug, M
Reiss, P
Lange, J
Frissen, PHJ
van der Ende, ME
Bosboom, M
Baas, C
Milazzo, F
Moroni, M
Panebianco, R
Clotet, B
Artigas, JMG
Gonzalez-Lahoz, J
Leal, M
Rodriguez-Lopo, C
Gandarias, B
Gazzard, B
Johnson, M
McKinley, S
Page, V
Watkins, K
Sandstrom, E
Belsey, E
Darbyshire, J
Chodakewitz, J
Isaacs, R
Jonas, L
Meibohm, A
Coughlan, M
Fiddian, P
Gartland, M
Harrigan, R
Larder, B
Maguire, M
Millard, J
Moore, S
Patel, K
Shortino, D
Tisdale, M
Vafidis, I
Yeo, J
Citation: M. Gartland et al., AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients, AIDS, 14(4), 2000, pp. 367-374
Authors:
Montaner, J
Molina, C
Alvarez-Sabin, J
Ordi, J
Citation: J. Montaner et al., Neurological manifestations of Schonlein-Henoch purpura: cerebral vasculitis or reversible posterior leukoencephalopathy syndrome?, MED CLIN, 115(17), 2000, pp. 677-677
Authors:
Phillips, P
Kwiatkowski, MB
Copland, M
Craib, K
Montaner, J
Citation: P. Phillips et al., Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy, J ACQ IMM D, 20(2), 1999, pp. 122-128
Authors:
Lacey, L
Hopkinson, PK
Montaner, J
Leblanc, F
Gill, MJ
Citation: L. Lacey et al., An evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing regimens in HIV infection - Canadian perspective, PHARMACOECO, 15, 1999, pp. 55-66
Authors:
FitzGerald, JM
Patrick, DM
Strathdee, S
Rekart, M
Elwood, RK
Schecter, MT
Montaner, J
O'Shaughnessy, M
Citation: Jm. Fitzgerald et al., Use of incentives to increase compliance for TB screening in a population of intravenous drug users, INT J TUBE, 3(2), 1999, pp. 153-155
Authors:
Molina, C
Sabin, JA
Montaner, J
Rovira, B
Abilleira, S
Codina, A
Citation: C. Molina et al., Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction - A case-control study, STROKE, 30(11), 1999, pp. 2296-2301